KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $776.0 million.

  • Bristol Myers Squibb's Short-term Investments rose 28039.22% to $776.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $776.0 million, marking a year-over-year increase of 28039.22%. This contributed to the annual value of $513.0 million for FY2024, which is 3713.24% down from last year.
  • Bristol Myers Squibb's Short-term Investments amounted to $776.0 million in Q3 2025, which was up 28039.22% from $1.0 billion recorded in Q2 2025.
  • Bristol Myers Squibb's 5-year Short-term Investments high stood at $3.0 billion for Q4 2021, and its period low was $130.0 million during Q4 2022.
  • Moreover, its 5-year median value for Short-term Investments was $816.0 million (2023), whereas its average is $1.1 billion.
  • In the last 5 years, Bristol Myers Squibb's Short-term Investments tumbled by 9564.78% in 2022 and then soared by 52769.23% in 2023.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Short-term Investments stood at $3.0 billion in 2021, then crashed by 95.65% to $130.0 million in 2022, then surged by 527.69% to $816.0 million in 2023, then tumbled by 37.13% to $513.0 million in 2024, then soared by 51.27% to $776.0 million in 2025.
  • Its Short-term Investments was $776.0 million in Q3 2025, compared to $1.0 billion in Q2 2025 and $907.0 million in Q1 2025.